Luigi Boiardi

Reggio Nell'emilia, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 85 publications

Epidemiology of eosinophilic granulomatosis with polyangiitis in Northern Italy: a population-based capture-recapture study.

Epidemiology of eosinophilic granulomatosis with polyangiitis in Northern Italy: a population-based capture-recapture study.

Journal: Seminars in arthritis and rheumatism

Published: March 22, 2026

The influence of baseline aortitis on aortic dilation risk in GCA: a multicentre imaging study.

The influence of baseline aortitis on aortic dilation risk in GCA: a multicentre imaging study.

Journal: Rheumatology (Oxford, England)

Published: July 30, 2025

Exploring total inflammatory vascular volume as a diagnostic and prognostic biomarker in giant cell arteritis.

Exploring total inflammatory vascular volume as a diagnostic and prognostic biomarker in giant cell arteritis.

Journal: Rheumatology (Oxford, England)

Published: January 26, 2025

Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: a multicentre retrospective study.

Effectiveness of intravenous infliximab versus subcutaneous adalimumab in Takayasu arteritis: a multicentre retrospective study.

Journal: Rheumatology (Oxford, England)

Published: October 28, 2024

Glucocorticoid boluses followed by tocilizumab in giant cell arteritis patients: effects on peripheral blood monocytes and lymphocytes.

Glucocorticoid boluses followed by tocilizumab in giant cell arteritis patients: effects on peripheral blood monocytes and lymphocytes.

Journal: Frontiers in immunology

Published: October 23, 2024

Does tocilizumab eliminate inflammation in GCA? A cohort study on repeated temporal artery biopsies.

Does tocilizumab eliminate inflammation in GCA? A cohort study on repeated temporal artery biopsies.

Journal: RMD open

Published: October 15, 2024

Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies.

Genes deregulated in giant cell arteritis by Nanostring nCounter gene expression profiling in temporal artery biopsies.

Journal: RMD open

Published: June 01, 2024

Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study.

Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: results from the extension of the TOPAZIO study.

Journal: Rheumatology (Oxford, England)

Published: May 07, 2024

Comment on: Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study. Reply.

Comment on: Treatment of giant cell arteritis with ultra-short glucocorticoids and tocilizumab: the role of imaging in a prospective observational study. Reply.

Journal: Rheumatology (Oxford, England)

Published: February 15, 2024

Eosinophilic giant cell arteritis: A different subset of disease?

Eosinophilic giant cell arteritis: A different subset of disease?

Journal: Seminars in arthritis and rheumatism

Published: November 06, 2023

miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritis.

miR-146a and miR-146b regulate the expression of ICAM-1 in giant cell arteritis.

Journal: Journal of autoimmunity

Published: September 30, 2023

Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study.

Effectiveness and safety of a 26-week taper regimen of glucocorticoid in GCA patients: Results from a prospective cohort study.

Journal: Seminars in arthritis and rheumatism

Published: September 15, 2023

Showing 1-12 of 85

Last Updated: 09/26/2026